Formed through the union of SAFC, a division of Sigma-Aldrich, and JRH Biosciences, SAFC Biosciences is a global developer and manufacturer of cell culture products and custom services with a proven track record in marketed biopharmaceuticals. With six cGMP global manufacturing facilities, SAFC Biosciences' portfolio supports the biopharmaceutical drug pipeline from R&D through bulk manufacture. Backed by excellent regulatory support, customers have confidence in all aspects of safety, consistency, quality and guarantee of supply.

SAFC Biosciences' platforms include proprietary serum-free media designed for therapeutic protein and monoclonal antibody production; for virus and vaccine production; and for protein production in insect cells. Also available is a range of classical media, as well as specialty products, such as buffers, detachment factors, growth factors and protein components, supplements and reagents. SAFC Biosciences sources animal sera in USA, Australia and New Zealand.

Key to the SAFC Biosciences offering is expertise in custom products and services, including cell culture media development and optimization programs, custom formulations and packaging and extensive technical support. imMEDIAte ADVANTAGE^TM provides a quality alternative for small volume media needs. Through BIOEAZE^TM custom or standard disposable bags and bioprocessing systems are offered.